Avenue Therapeutics (ATXI) Institutional Ownership $2.00 -0.01 (-0.50%) (As of 11/21/2024 ET) Add Compare Share Share Ownership Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOwnershipSEC FilingsShort InterestSustainabilityTrends Institutional Ownership Changes (13F Filings) for Avenue Therapeutics (NASDAQ:ATXI)CurrentInstitutional OwnershipPercentage17.34%Number ofInstitutional Buyers(last 12 months)2TotalInstitutional Inflows(last 12 months)$289.89KNumber ofInstitutional Sellers(last 12 months)0 Get ATXI Insider Trade Alerts Want to know when executives and insiders are buying or selling Avenue Therapeutics stock? Sign up for InsiderTrades.com's daily newsletter to get the latest insider transactions delivered to your inbox daily. Email Address Skip Chart & View Institutional Buying and Selling Data ATXI Institutional Buying and Selling by Quarter Ad Crypto 101 MediaBlackrock’s Sending THIS Crypto Higher on PurposeIt's a groundbreaking opportunity that could be poised for extraordinary gains. The catalyst behind this surge is a massive new blockchain development…YES, I WANT THE #1 CRYPTO NOW Avenue Therapeutics Major Shareholders & Ownership History Export to ExcelReporting DateMajor Shareholder NameShares HeldMarket Value% of PortfolioQuarterly Change in SharesOwnership in CompanyDetails10/18/2024Moss Adams Wealth Advisors LLC11,000$27K0.0%N/A1.169% 8/15/2024 Armistice Capital LLC75,000$262K0.0%N/A7.970% 1/28/2022National Asset Management Inc.71,338$65K0.0%-20.1%0.376% 11/16/2021National Asset Management Inc.89,237$133K0.0%-29.2%0.531% 10/19/2021 Kestra Advisory Services LLC22,500$34K0.0%N/A0.134% 9/17/2021 Virtu Financial LLC26,373$66K0.0%N/A0.157% Get the Latest News and Ratings for ATXI and Related StocksEnter your email address below to receive the latest news and analysts' ratings for Avenue Therapeutics and its competitors with MarketBeat's FREE daily newsletter. 9/3/2021Parametric Portfolio Associates LLC10,554$26K0.0%-59.2%0.063% 8/16/2021 Occudo Quantitative Strategies LP14,398$36K0.0%N/A0.086% 8/13/2021 Renaissance Technologies LLC78,314$197K0.0%N/A0.468% 8/13/2021 Northern Trust Corp13,767$35K0.0%-82.1%0.082% 8/13/2021 Geode Capital Management LLC79,556$199K0.0%-40.0%0.475% 8/13/2021 Vanguard Group Inc.449,982$1.13M0.0%-35.5%2.687% 8/12/2021 XTX Topco Ltd10,864$27K0.0%N/A0.065% 8/12/2021 Advisory Services Network LLC35,121$88K0.0%N/A0.210% 8/12/2021Ergoteles LLC30,400$76K0.0%N/A0.182% 8/10/2021National Asset Management Inc.126,037$317K0.0%-26.1%0.753% 5/20/2021Axiom Investment Management LLC10,000$60K0.0%N/A0.060% 5/19/2021 Squarepoint Ops LLC11,668$71K0.0%N/A0.070% 5/17/2021 Goldman Sachs Group Inc.17,319$105K0.0%N/A0.103% 5/13/2021 Trexquant Investment LP13,874$84K0.0%N/A0.083% 5/13/2021Axiom Investment Management LLC10,000$60K0.0%N/A0.060% 5/13/2021 Barclays PLC5,568$34K0.0%+159.0%0.033% 5/12/2021 Northern Trust Corp77,049$467K0.0%-6.8%0.460% 5/12/2021 Geode Capital Management LLC132,594$804K0.0%+5.9%0.792% 2/24/2021 Virtu Financial LLC17,469$104K0.0%N/A0.104% 2/19/2021 JPMorgan Chase & Co.17,102$101K0.0%+260.2%0.102% 2/17/2021 Jane Street Group LLC13,288$79K0.0%N/A0.079% 2/11/2021 Northern Trust Corp82,691$492K0.0%+2.1%0.494% 2/9/2021 Wells Fargo & Company MN16,406$98K0.0%-13.2%0.098% 2/5/2021BlackRock Inc.361,486$2.15M0.0%+5.5%2.158% 2/4/2021National Asset Management Inc.167,787$999K0.1%+15.0%1.002% 11/13/2020 Morgan Stanley22,706$246K0.0%+270.9%0.136% 11/10/2020 State Street Corp73,316$794K0.0%+9.5%0.438% 11/6/2020BlackRock Inc.342,742$3.71M0.0%+7.4%2.052% (Data available from 1/1/2016 forward) ATXI Institutional Ownership - Frequently Asked Questions Who are the largest shareholders of ATXI shares? During the previous two years, the following institutional investors and hedge funds held shares of Avenue Therapeutics shares: Armistice Capital LLC ($262K), Moss Adams Wealth Advisors LLC ($27K).Learn more on ATXI's institutional investors. What percentage of Avenue Therapeutics stock is owned by institutional investors? 17.34% of Avenue Therapeutics stock is owned by institutional investors. Learn more on ATXI's institutional investor holdings. Which institutional investors have been buying Avenue Therapeutics stock? The following institutional investors have purchased Avenue Therapeutics stock in the last 24 months: Armistice Capital LLC ($75K), and Moss Adams Wealth Advisors LLC ($11K). How much institutional buying is happening at Avenue Therapeutics? Institutional investors have bought a total of 86,000 shares in the last 24 months. This purchase volume represents approximately $289.89K in transactions. Related Companies Edesa Biotech Major Shareholders IN8bio Major Shareholders Akari Therapeutics Major Shareholders NRx Pharmaceuticals Major Shareholders Kazia Therapeutics Major Shareholders AIM ImmunoTech Major Shareholders PharmaCyte Biotech Major Shareholders Sol-Gel Technologies Major Shareholders NLS Pharmaceutics Major Shareholders Sensei Biotherapeutics Major Shareholders This page (NASDAQ:ATXI) was last updated on 11/21/2024 by MarketBeat.com Staff From Our PartnersThe Crypto That’s Making Wall Street SweatThe Crypto Wall Street Is Desperate to Hide It's happening now, right under everyone's radar. Big tech gian...Crypto 101 Media | SponsoredMissed Nvidia? Watch this ASAPThis little-known project that Bill Gates has been quietly working on that’s about to unleash an AI breakthrou...Brownstone Research | SponsoredMusk’s new company could top a trillion?The investment legend who predicted the rise of Bitcoin, Facebook and streaming services like Netflix… Just...Paradigm Press | Sponsored24/7 Automated Profits in CryptoWhat if you could make consistent daily profits in crypto with minimal effort? Beyond trading lies a vast w...Crypto Swap Profits | Sponsored“This Changes Everything” - Trump Hands Millions Massive IRS GiftNow it's your time to return the favor by taking advantage of this tax "revenge loophole." Because even as ...Colonial Metals | SponsoredCrypto’s next big bull run?Juan Villaverde may be America’s top crypto expert. And he says something big is coming for crypto – on Nov...Weiss Ratings | SponsoredUnveiled: NVIDIA’s "Secret Royalty" ProgramDid you know that there's an investment that will give you the opportunity to collect "royalties" every time N...Behind the Markets | SponsoredTim Sykes’ Urgent Trade Alert: “Make this move now”WARNING: 80 Wall Street banks are gearing up for MASSIVE D.C. shock This $2 trillion D.C. shock is NOT abou...Timothy Sykes | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Avenue Therapeutics, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Avenue Therapeutics With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
